Masako Nakamura

Senior Vice President, Head of Asia at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Masako Nakamura's Colleagues at Alnylam Pharmaceuticals
Tanya Fischer

Vice President, CNS and Complement Clinical Development

Contact Tanya Fischer

Larry Fox

Manufacturing Supervisor Process Science

Contact Larry Fox

Andrew Slugg

Senior Vice President, Head of Global Regulatory Affairs

Contact Andrew Slugg

Jeff Axline

Director, Materials Management

Contact Jeff Axline

Sherrie Tafuri

Sr Director Onpattro PM, Head Commercial Stage PM

Contact Sherrie Tafuri

Joe Govoni

Associate Director

Contact Joe Govoni

View All Masako Nakamura's Colleagues
Masako Nakamura's Contact Details
HQ
(617) 551-8200
Location
Boston, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Masako Nakamura's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Masako Nakamura
Masako Nakamura currently works for Alnylam Pharmaceuticals.
Masako Nakamura's role at Alnylam Pharmaceuticals is Senior Vice President, Head of Asia.
Masako Nakamura's email address is ***@alnylam.com. To view Masako Nakamura's full email address, please signup to ConnectPlex.
Masako Nakamura works in the SaaS industry.
Masako Nakamura's colleagues at Alnylam Pharmaceuticals are Tanya Fischer, Larry Fox, Bill Frederick, Andrew Slugg, Jeff Axline, Sherrie Tafuri, Joe Govoni and others.
Masako Nakamura's phone number is (617) 551-8200
See more information about Masako Nakamura